INTERNATIONAL PATENT: HEPQUANT, LLC FILES APPLICATION FOR "MEASURING RISK OF ADVERSE CLINICAL EVENTS IN CHRONIC LIVER DISEASE"

GENEVA, May 12 -- HEPQUANT, LLC (8110 E Union AveSuite 750Denver, Colorado 80237) filed a patent application (PCT/US2025/053080) for "MEASURING RISK OF ADVERSE CLINICAL EVENTS IN CHRONIC LIVER DISEASE" on Oct 29, 2025. With publication no. WO/2026/096608, the details related to the patent application was published on May 07, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): KITTELSON, John M. (512 Benton Ave.Missoula, Montana 59801), MCRAE, Michael P. (3611 Corondo CtHouston, Texas 77005), EVERSON, Gregory Thomas (6112 South Nome CourtEnglewood, Colorado 80111)

Abstract: A method is provided ...